CN105596373B - A kind of extraction purification from bilein contains the total extract method of chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid - Google Patents

A kind of extraction purification from bilein contains the total extract method of chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid Download PDF

Info

Publication number
CN105596373B
CN105596373B CN201510845226.6A CN201510845226A CN105596373B CN 105596373 B CN105596373 B CN 105596373B CN 201510845226 A CN201510845226 A CN 201510845226A CN 105596373 B CN105596373 B CN 105596373B
Authority
CN
China
Prior art keywords
acid
bilein
freeze
ethyl alcohol
extraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510845226.6A
Other languages
Chinese (zh)
Other versions
CN105596373A (en
Inventor
毕力格
李汉青
金亮
蔚璐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inner Mongolia Autonomous Region Mongolian Medicine Research Institute
Original Assignee
Inner Mongolia Autonomous Region Mongolian Medicine Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inner Mongolia Autonomous Region Mongolian Medicine Research Institute filed Critical Inner Mongolia Autonomous Region Mongolian Medicine Research Institute
Priority to CN201510845226.6A priority Critical patent/CN105596373B/en
Publication of CN105596373A publication Critical patent/CN105596373A/en
Application granted granted Critical
Publication of CN105596373B publication Critical patent/CN105596373B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/413Gall bladder; Bile

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses extraction purification in a kind of bilein contain chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid total extract method, its method for extraction and purification mainly includes: taking a certain amount of ox courage cream powder, it is impregnated and (ox courage cream: ethyl alcohol=1: 2), is extracted in ultrasonic extractor with 95% ethyl alcohol;Ethyl acetate is added in extracting solution and places 30min precipitating, filters, concentration is freeze-dried spare.A certain amount of processed macroreticular resin is weighed in glass chromatography column, 40% ethyl alcohol of bilein extract freeze-drying powder is dissolved, is then slowly added into lysate in analysis column, elution filtering, concentration is freeze-dried to obtain product.High using ultrasonic extraction bilein recovery rate, extraction time is shorter, and technological operation is easy.Present invention employs Amberlyst process to isolate and purify bilein extract, and what this method was separated, and purified, being enriched with makes good use of, and facilitates the extraction purification of chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid.

Description

One kind extraction purification from bilein contains chenodeoxycholic acid, ursodesoxycholic acid, pig and goes The total extract method of oxycholic acid
Technical field
The present invention relates to drug ingedients to extract field, particularly, is related to extraction purification in a kind of bilein and contains goose deoxidation Cholic acid, ursodesoxycholic acid, hyodesoxycholic acid total extract method.
Background technique
Fel bovis is the gallbladder of bovid ox Bostaurus domesticus Gmelin or buffalo Bubalus L. Juice.Fel bovis it is medicinal, first recorded in one book of Shennong's Herbal of Han dynasty, be classified as middle product, later age book on Chinese herbal medicine also when have discussion.This product Bitter is cold in nature, has and clears liver and improve vision, normalizing the secretion and discharge of bile, the efficacy of removing toxicity for detumescence effect, is widely used in treatment the hot hot eyes of liver swelling and pain, and children are frightened Wind, carbuncle sore tumefacting virus and constipation, the diseases such as quench one's thirst.Bilein (dry bile) is anaesthetic special medicinal material, the entitled crow of anaesthetic and benevolence-again Su Su has the effect of calming down association's day, callus, removing toxic substances, improving eyesight.It is sick, significant in efficacy with toxication that Mongolian medicine is clinically used for association's day.At present Think to mainly contain the ingredients such as bilirubin, bile acid, cholesterol, inorganic elements, albumen and amino acid in bilein.
Contain in fel bovis there are many Cholic acids chemical component, is deoxygenated including chenodeoxycholic acid, ursodesoxycholic acid and pig Cholic acid, but its content is lower.
Chenodeoxycholic acid clinically not only with the drug of dissolving cholesterol class calculus and correction saturation bile, also has aobvious Land relieving asthma, be anti-inflammatory, antibechic and the effects of eliminating the phlegm.Chenodeoxycholic acid is also the synthesis material of expensive ursodesoxycholic acid, they It is all the active drug for treating disease of biliary tract.
Ursodesoxycholic acid has cell membrane stability effect, has detoxication to hepatotoxicity substance, while it is low to increase liver The intake of density lipoprotein to increase the output of liver cell lipid, while increasing fatty acid oxidation or triglyceride conversion, delays Solve hepatic cell fattydegeneration.
Hyodesoxycholic acid has the effects that reducing blood lipid, antispastic, eliminating the phlegm, is the important component of artificial ox sulphur, clinically can be used In treatment hyperlipemia, tracheitis and the indigestion as caused by disease in the liver and gallbladder, to bacillus pertussis, corynebacterium diphtheriae, golden yellow Staphylococcus also has inhibiting effect.
Extracting in the prior art not from bilein has chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid always to mention Object technical matters is taken to report.
1. the total extract that the present invention only prepares chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid from bilein; What is mainly utilized is macroreticular resin;
2. these macroreticular resins were only applied in our study, others is not yet reported that;
3. the advantage of macroreticular resin is mainly the compound of gathering trace, resin is mainly utilized in our study Enrichment and purification.
Summary of the invention
It is an object of the present invention to provide extraction purifications in a kind of bilein to contain chenodeoxycholic acid, ursodeoxycholic The method of sour, hyodesoxycholic acid total extract.
Particularly, the extraction purification from bilein contain chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid it is total The method of extract is the working principle for effectively being extracted using macroreticular resin, effectively removing the gred, be effectively enriched with, effectively purifying;It utilizes The quality-high and inexpensive ethyl alcohol without concentration reaches the purifying of last total extract;Total extract after purification can carry out anaesthetic The reform of preparation formulation is studied, and specific steps include:
(1) 95% EtOH Sonicate of bilein extracts (supersonic frequency 50-80Hz): taking a certain amount of bilein that certain volume is added 95% ethyl alcohol (material ratio 1: 2) ultrasonic extraction 3 times, each 1h, each time after ultrasonic extraction, appropriate second is added on extracting solution Acetoacetic ester places 30min precipitating, uses filtered on buchner funnel after waiting precipitating completely, precipitating is again plus the continuation of 95% ethyl alcohol mentions for the second time It takes, above method is extracted three times.Finally merge filtered fluid.
(2) recycling concentration: recycling concentration filtrate is concentrated into no ethanol flavor.
(3) be freeze-dried: concentrate freeze-drying obtains bilein freeze-dried powder.
(4) 40% EtOH Sonicate (supersonic frequency 50-80Hz) of bilein freeze-dried powder dissolves, spare.
(5) macroporous absorbent resin isolates and purifies: weighing 1kg processing resin in glass chromatography column, is slowly added to above-mentioned molten Liquid is solved, successively with 20%, 40%, 60%, 80% ethanol elution, filtering, 60% and 80% ethanol eluate of collection, concentration 60% With 80% ethanol eluate, it is freeze-dried 60% and 80% ethyl alcohol concentrate.
Particularly, a variety of macroreticular resins have been used in this experiment, including D101 type, D001 type, HPD-100 type, HPD-750 type, HPD-722 type, SIP1300 type, X-5 type.
Particularly, resin is by pretreatment: 95% appropriate amount of ethanol of resin is impregnated for 24 hours, soaked resin is filled into pillar, First 95% ethyl alcohol rinses, and is then rinsed with purified water, rinses until white opacity do not occur and not having ethanol flavor, then with 5% Hydrochloric acid and 5% sodium hydroxide rush pillar, respectively rush 5 column volumes, and last 5~6 column volume purified water is rinsed to neutral spare.
Attached drawing summary description
Attached drawing 1 gives a kind of specific extraction purification separation process figure of anaesthetic compound of the present invention.
Attached drawing 2 shows that 60% and 80% bilein freeze-dried powder of the invention is identified by TLC and goes containing chenodeoxycholic acid, bear The thin layer figure of oxycholic acid and hyodesoxycholic acid.It is compareed respectively with chenodeoxycholic acid, ursodesoxycholic acid and hyodesoxycholic acid standard items Contain chenodeoxycholic acid, ursodesoxycholic acid and hyodesoxycholic acid in 60% and 80% bilein freeze-dried powder.The knot of Fig. 2 thin layer identification Fruit, which shows to contain in 60% and 80% bilein freeze-dried powder, compares condition with chenodeoxycholic acid, ursodesoxycholic acid and hyodesoxycholic acid Same point (identical Rf value) and identical color reaction.
Thin layer identifies specific implementation method:
Solvent: toluene-glacial acetic acid-water (19.5: 10: 0.3) ratio is configured to solvent, and adds a drop formic acid.
Color developing agent: 10% ethanol solution of sulfuric acid color developing agent: the sulfuric acid solution that pharmacopeia measures 2.85ml is abided by, is diluted with ethanol to 50ml is made.
Specific embodiment
Embodiment 1
600g bilein is weighed, is put into triangular flask, 95% ethyl alcohol of 1.2L is added, is covered, is put into ultrasonic wave and extracts, 30 DEG C of ultrasonic temperature, time 30min, 1h is extracted every time, is extracted 3 times, it is on extracting solution plus appropriate after each ultrasonic extraction Ethyl acetate places 30min precipitating, waits and filters after extracting liquid precipitate, finally merges filtered fluid, and recycling concentration is freeze-dried 496g bilein is spare.
496g bilein freeze-dried powder adds appropriate 40% EtOH Sonicate to dissolve, the D101 resin 1kg that will be handled well in chromatographic column, It is slowly added to 40% ethyl alcohol bilein solution, absorption parsing elution is collected 60% and 80% ethanol eluate, filtered, and concentration is cold Dry product is lyophilized.60% ethanol eluate freeze-dried powder 29.897g, 80% ethanol eluate freeze-dried powder 21.182g.
60% and 80% bilein freeze-dried powder is identified by TLC deoxygenates gallbladder containing chenodeoxycholic acid, ursodesoxycholic acid and pig Acid, wherein chenodeoxycholic acid, ursodesoxycholic acid and hyodesoxycholic acid are enriched in 60% bilein freeze-dried powder.
Embodiment 2
Pharmacodynamic study is carried out to 60% and 80% bilein freeze-dried powder, further confirms Mongolian medicinal preparation or anaesthetic prescription In, the pharmacological action of the symptoms such as treatment cholelithiasis, hyperlipidemia, indigestion, wherein with the freeze-drying of 60% ethyl alcohol position bilein Powder carries out for pharmacodynamic study.
(1) to the influence of bile secretion
Using biliary canulization method, taking weight is 180-200g male rat 16, is randomly divided into two groups, i.e. blank control group And administration group, each 8 male rats, blank group give stomach-filling and give physiological saline sodium carboxymethylcellulose suspension, administration group fills The 60% ethyl alcohol position bilein freeze-dried powder of stomach 100mg/kg 30 minutes after medicine, is anaesthetized with 20% urethane, and bile duct is inserted in operation, Collect two hours choleresis.
Experimental result illustrates that 60% ethyl alcohol position bilein freeze-dried powder has significant choleretic effect compared with control group, can obviously increase The secretory volume for adding bile, experimental result is shown in (tables 1).
The influence that (table 1) 60% ethyl alcohol position bilein freeze-dried powder secretes rat bile
(2) to the influence of serum cholesterol
Using one sulfuric acid development process of high-speed rail, take weight 18-22g mouse 16, be randomly divided into two groups, i.e., blank control group and Administration group, each 8 mouse, blank group give stomach-filling and give physiological saline sodium carboxymethylcellulose suspension, administration group stomach-filling The 60% ethyl alcohol position bilein freeze-dried powder of 300mg/kg, successive administration 4 days.5 hours after last time is administered, eyeball is extractd Blood is taken, after preparing serum, measures its cholesterol concentration.
The result shows that there is significant difference between administration group and control group, illustrate 60% ethyl alcohol position bilein freeze-dried powder Effect is substantially reduced to serum cholesterol.Experimental result is shown in (tables 2)
Influence of (table 2) the 60% ethyl alcohol position bilein freeze-dried powder to mice serum cholesterol concentration

Claims (4)

1. in a kind of bilein extraction purification contain chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid total extract side Method, it is characterised in that comprising steps of
(1) 95% EtOH Sonicate of bilein extracts, 50~80Hz of supersonic frequency: taking a certain amount of bilein that certain volume 95% is added Ethyl alcohol, material ratio 1: 2 ultrasonic extraction 3 times, each 1h, add appropriate acetic acid second each time on extracting solution after ultrasonic extraction Ester places 30min precipitating, uses filtered on buchner funnel after waiting precipitating completely, and precipitating is again plus 95% ethyl alcohol continues second of extraction, with Upper method is extracted three times, and filtered fluid is finally merged;
(2) recycling concentration: recycling concentration filtrate is concentrated into no ethanol flavor;
(3) be freeze-dried: concentrate freeze-drying obtains bilein freeze-dried powder;
(4) 40% EtOH Sonicate of bilein freeze-dried powder, 50~80Hz of supersonic frequency dissolution are spare;
(5) macroporous absorbent resin isolates and purifies: 1kg processing resin is weighed in glass chromatography column, is slowly added to above-mentioned lysate, Successively with 20%, 40%, 60%, 80% ethanol elution, filtering, 60% and 80% ethanol eluate of collection, 60% He of concentration 80% ethanol eluate is freeze-dried 60% and 80% ethyl alcohol concentrate;
Wherein, the resin is D101 type resin.
2. the method according to claim 1, wherein the method for processing resin are as follows: impregnate for 24 hours 95% appropriate amount of ethanol of resin, will soak The resin dress pillar soaked, first 95% ethyl alcohol rinses, and is then rinsed with purified water, and rinsing to there is not white opacity does not have ethyl alcohol Until taste, pillar then is rushed with 5% hydrochloric acid and 5% sodium hydroxide, respectively rushes 5 column volumes, last 5~6 column volume purified water punching It is washed till neutral spare.
3. according to claim 1-2 any methods preparations containing chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid it is total Extract.
4. Mongolian medicinal preparation made of total extract according to claim 3, it is characterised in that dosage form include pill, soft capsule, Capsule, granule, injection, tablet, cataplasm, ointment, gelling agent, skin-permeable and control-released plaster, spray.
CN201510845226.6A 2015-11-27 2015-11-27 A kind of extraction purification from bilein contains the total extract method of chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid Active CN105596373B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510845226.6A CN105596373B (en) 2015-11-27 2015-11-27 A kind of extraction purification from bilein contains the total extract method of chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510845226.6A CN105596373B (en) 2015-11-27 2015-11-27 A kind of extraction purification from bilein contains the total extract method of chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid

Publications (2)

Publication Number Publication Date
CN105596373A CN105596373A (en) 2016-05-25
CN105596373B true CN105596373B (en) 2019-07-19

Family

ID=55977108

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510845226.6A Active CN105596373B (en) 2015-11-27 2015-11-27 A kind of extraction purification from bilein contains the total extract method of chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid

Country Status (1)

Country Link
CN (1) CN105596373B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101781350A (en) * 2010-02-02 2010-07-21 浙江大学 Method for purifying ursodeoxycholic acid by mixed solvent
CN102552325A (en) * 2010-12-27 2012-07-11 福建归真堂药业股份有限公司 Bear gall extract, preparation method thereof and application thereof to preparation of fatty liver treatment medicament

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101781350A (en) * 2010-02-02 2010-07-21 浙江大学 Method for purifying ursodeoxycholic acid by mixed solvent
CN102552325A (en) * 2010-12-27 2012-07-11 福建归真堂药业股份有限公司 Bear gall extract, preparation method thereof and application thereof to preparation of fatty liver treatment medicament

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
猪胆粉中结合型胆甾酸的化学成分及生物活性研究;何姣;《中国博士学位论文全文数据库 医药卫生科技辑》;20121115(第11期);第14页第5-6行

Also Published As

Publication number Publication date
CN105596373A (en) 2016-05-25

Similar Documents

Publication Publication Date Title
CN101294186A (en) Method for preparing donkey-hide gelatin oligopeptide
CN101033445B (en) Wine capable of protecting liver and preserving one's health and preparing method thereof
CA2486378A1 (en) Preparation and application of total salvianolic acid
CN107693559A (en) The preparation method of Notogineng Extract
CN110075213A (en) The method of extraction purification general flavone and total saposins from Rootlet Ophiopogonis
CN106138241A (en) A kind of Chinese medicine composition of relieving itching and eliminating swelling and preparation method thereof after mosquito bite
CN108403950A (en) A kind of extraction and purification method of dendrobium candidum leaf flavonoids
CN105832789A (en) Method for preparing saponin enriched product through high-pressure microwave assisted semi-bionic extraction
CN105998103A (en) Chestnut flower activated extract and preparation method and application thereof
CN105267257A (en) Preparation method of ginkgo leaf extract
CN105596373B (en) A kind of extraction purification from bilein contains the total extract method of chenodeoxycholic acid, ursodesoxycholic acid, hyodesoxycholic acid
CN101982184A (en) Preparation method of taraxacum extract
CN106883306A (en) A kind of extraction separation method of the sunflower stem core polysaccharide with antitumor activity
CN108524668B (en) Preparation method of Chinese wolfberry extract with repairing and treating effects on drug-induced liver injury
CN106860489A (en) A kind of extracting method of myrica rubra leaf polyphenol
CN1748725A (en) Process for preparing semen momordicae seed extract containing triterpene saponin component
CN205740840U (en) A kind of isolated and purified device of high-purity silymarin
CN106109501A (en) Can the effective ingredient of anti-intestinal EV 71 virus and preparation method in a kind of Holotrichia diomphalia Bates
CN104474068B (en) Fevervine extract and application thereof
CN103585226B (en) A kind of preparation method of Herba Elephantopi Mollis extract and application thereof
CN109223739B (en) Composition and preparation method and application thereof
CN103285113B (en) Pharmaceutical composition for preventing and/or treating diabetes mellitus
CN101450962B (en) Method for extracting oleanolic acid from Kandelia candel leaf
CN101721450B (en) Application of oriental cocklebur root chloroform extract used for treating peritonitis
CN108653358A (en) A kind of preparation method of root of Low serpentroot chromocor extract

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant